Phanes Therapeutics
- Founded: 2016
- Location: San Diego, CA
- Employee range: 1 - 10
- Clinical stage: Clin1
- Therapy area: Solid tumors
- Drug types: ONC
- Lead product: PT199
- Product link: https://www.phanesthera.com/pipeline/
- Funding: $40M B May 2021
phanesthera.com linkedin.com job board
Short description:
Treatments for solid tumors and eye diseases
Drug notes:
PT886 Clin1 multiple cancers (ODD); PTC-217 Clin1 cancers; 15 add'l products early stage
Long description:
Phanes Therapeutics is focused on innovative drug discovery in immuno-oncology. Antibiotic-based biologics have much potential in therapies due to their specificity and modularity. Phanes is building native IgG-like bispecific antibodies that enhance drug-like properties. Currently, Phane has three technology platforms: PACbody, to create bispecific antibodies, SPECpair, to enhance manufacturability of bispecific antibodies and ATACCbody, to build bispecific antibodies with modulated activities. Using this approach, Phanes has established a diverse pipeline with some programs in clinical studies.
Jobs:
© 2024 Work In Biotech LLC
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com